119 related articles for article (PubMed ID: 27500753)
1. Use of antibiotics is associated with lower enterolactone plasma concentration.
Bolvig AK; Kyrø C; Nørskov NP; Eriksen AK; Christensen J; Tjønneland A; Knudsen KE; Olsen A
Mol Nutr Food Res; 2016 Dec; 60(12):2712-2721. PubMed ID: 27500753
[TBL] [Abstract][Full Text] [Related]
2. Triclosan and prescription antibiotic exposures and enterolactone production in adults.
Adgent MA; Rogan WJ
Environ Res; 2015 Oct; 142():66-71. PubMed ID: 26114916
[TBL] [Abstract][Full Text] [Related]
3. Prediagnosis plasma concentrations of enterolactone and survival after colorectal cancer: the Danish Diet, Cancer and Health cohort.
Kyrø C; Frederiksen K; Holm M; Nørskov NP; Knudsen KEB; Overvad K; Tjønneland A; Olsen A
Br J Nutr; 2019 Sep; 122(5):552-563. PubMed ID: 30173678
[TBL] [Abstract][Full Text] [Related]
4. Plasma enterolactone and risk of colon and rectal cancer in a case-cohort study of Danish men and women.
Johnsen NF; Olsen A; Thomsen BL; Christensen J; Egeberg R; Bach Knudsen KE; Loft S; Overvad K; Tjønneland A
Cancer Causes Control; 2010 Jan; 21(1):153-62. PubMed ID: 19844797
[TBL] [Abstract][Full Text] [Related]
5. Plasma enterolactone and breast cancer incidence by estrogen receptor status.
Olsen A; Knudsen KE; Thomsen BL; Loft S; Stripp C; Overvad K; Møller S; Tjønneland A
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2084-9. PubMed ID: 15598765
[TBL] [Abstract][Full Text] [Related]
6. Plasma enterolactone and incidence of endometrial cancer in a case-cohort study of Danish women.
Aarestrup J; Kyrø C; Knudsen KE; Weiderpass E; Christensen J; Kristensen M; Würtz AM; Johnsen NF; Overvad K; Tjønneland A; Olsen A
Br J Nutr; 2013 Jun; 109(12):2269-75. PubMed ID: 23114205
[TBL] [Abstract][Full Text] [Related]
7. Effect of Antibiotics and Diet on Enterolactone Concentration and Metabolome Studied by Targeted and Nontargeted LC-MS Metabolomics.
Bolvig AK; Nørskov NP; Hedemann MS; Foldager L; McCarthy-Sinclair B; Marco ML; Lærke HN; Bach Knudsen KE
J Proteome Res; 2017 Jun; 16(6):2135-2150. PubMed ID: 28294620
[TBL] [Abstract][Full Text] [Related]
8. Use of oral antimicrobials decreases serum enterolactone concentration.
Kilkkinen A; Pietinen P; Klaukka T; Virtamo J; Korhonen P; Adlercreutz H
Am J Epidemiol; 2002 Mar; 155(5):472-7. PubMed ID: 11867359
[TBL] [Abstract][Full Text] [Related]
9. Validation of FFQ-based assessment of dietary lignans compared with serum enterolactone in Swedish women.
Lin Y; Wolk A; Håkansson N; Peñalvo JL; Lagergren J; Adlercreutz H; Lu Y
Br J Nutr; 2013 May; 109(10):1873-80. PubMed ID: 23006454
[TBL] [Abstract][Full Text] [Related]
10. Dietary determinants of plasma enterolactone.
Horner NK; Kristal AR; Prunty J; Skor HE; Potter JD; Lampe JW
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):121-6. PubMed ID: 11815409
[TBL] [Abstract][Full Text] [Related]
11. Factors Explaining Interpersonal Variation in Plasma Enterolactone Concentrations in Humans.
Hålldin E; Eriksen AK; Brunius C; da Silva AB; Bronze M; Hanhineva K; Aura AM; Landberg R
Mol Nutr Food Res; 2019 Aug; 63(16):e1801159. PubMed ID: 30817848
[TBL] [Abstract][Full Text] [Related]
12. An incident case-referent study on plasma enterolactone and breast cancer risk.
Hultén K; Winkvist A; Lenner P; Johansson R; Adlercreutz H; Hallmans G
Eur J Nutr; 2002 Aug; 41(4):168-76. PubMed ID: 12242585
[TBL] [Abstract][Full Text] [Related]
13. Pre-diagnostic plasma enterolactone concentrations and breast cancer prognosis among postmenopausal women - The Danish Diet, Cancer and Health cohort.
Kyrø C; Hansen L; Frederiksen K; Nørskov NP; Bach Knudsen KE; Eriksen AK; Holm M; Tjønneland A; Olsen A
Clin Nutr; 2018 Dec; 37(6 Pt A):2217-2225. PubMed ID: 29154112
[TBL] [Abstract][Full Text] [Related]
14. Determinants of serum enterolactone concentration.
Kilkkinen A; Stumpf K; Pietinen P; Valsta LM; Tapanainen H; Adlercreutz H
Am J Clin Nutr; 2001 Jun; 73(6):1094-100. PubMed ID: 11382665
[TBL] [Abstract][Full Text] [Related]
15. Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study.
Vanharanta M; Voutilainen S; Lakka TA; van der Lee M; Adlercreutz H; Salonen JT
Lancet; 1999 Dec 18-25; 354(9196):2112-5. PubMed ID: 10609816
[TBL] [Abstract][Full Text] [Related]
16. Serum enterolactone concentrations are low in colon but not in rectal cancer patients.
Tuomisto A; Nørskov NP; Sirniö P; Väyrynen JP; Mutt SJ; Klintrup K; Mäkelä J; Bach Knudsen KE; Mäkinen MJ; Herzig KH
Sci Rep; 2019 Aug; 9(1):11209. PubMed ID: 31371751
[TBL] [Abstract][Full Text] [Related]
17. High-Throughput LC-MS/MS Method for Direct Quantification of Glucuronidated, Sulfated, and Free Enterolactone in Human Plasma.
Nørskov NP; Kyrø C; Olsen A; Tjønneland A; Knudsen KE
J Proteome Res; 2016 Mar; 15(3):1051-8. PubMed ID: 26809233
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of plasma enterolactone and prostate cancer risk (Sweden).
Stattin P; Bylund A; Biessy C; Kaaks R; Hallmans G; Adlercreutz H
Cancer Causes Control; 2004 Dec; 15(10):1095-102. PubMed ID: 15801493
[TBL] [Abstract][Full Text] [Related]
19. Enterolactone concentrations and prognosis after postmenopausal breast cancer: assessment of effect modification and meta-analysis.
Seibold P; Vrieling A; Johnson TS; Buck K; Behrens S; Kaaks R; Linseisen J; Obi N; Heinz J; Flesch-Janys D; Chang-Claude J
Int J Cancer; 2014 Aug; 135(4):923-33. PubMed ID: 24436155
[TBL] [Abstract][Full Text] [Related]
20. Plasma enterolactone and risk of prostate cancer in middle-aged Swedish men.
Wallström P; Drake I; Sonestedt E; Gullberg B; Bjartell A; Olsson H; Adlercreutz H; Tikkanen MJ; Wirfält E
Eur J Nutr; 2018 Oct; 57(7):2595-2606. PubMed ID: 28884432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
